Search Orphan Drug Designations and Approvals
-
Generic Name: | filgrastim |
---|---|
Date Designated: | 01/27/2015 |
Orphan Designation: | Treatment of amyotrophic lateral sclerosis (ALS) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Neurovision Pharma GmbH Emil-Geis Str. 4 Grunwald Germany The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-